Clinical Trial Update: Efficacy and Tolerability of Sifrol® (Pramipexole) in Patients With Advanced Idiopathic Parkinson's Disease

View source ↗

Summary

The report summarizes the completed trial evaluating the efficacy and tolerability of Sifrol (pramipexole) in patients with advanced idiopathic Parkinson diseas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Sifrol (ropinirole)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Parkinson Disease | Status: COMPLETED